Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Abbisko Cayman Ltd
8ZDCurrent price
0.53 EUR
+0.033 EUR (+6.71%)
Last closed
4.19 HKD
Company
www.abbisko.com
ISIN
KYG0028A1085
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
2 695 150 801 HKD
Yield for 12 month
+16.98 %
1Y
3Y
5Y
10Y
15Y
8ZD
Abbisko Cayman Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule oncology therapies in Mainland China. The company's product candidates are primarily small molecules that focus on small molecule precision oncology and small molecule immuno-oncology therapeutic areas. It is also involved in the research and development in areas of biomedical and biotechnology; and provision of technical and technical consultation services. Abbisko Cayman Limited has co-discovery collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of novel molecules; and BeiGene, Ltd. on the combination therapy of fexagratinib and tislelizumab, an anti-PD-1 antibody for treating urothelial cancer with FGFR2/3 genetic alterations. The company was founded in 2016 and is headquartered in Shanghai, the People's Republic of China. Address: Building 3, Shanghai, China
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
88.24 HKDP/E ratio
–Dividend Yield
–Current Year
+19 061 862 HKD
Last Year
–
Current Quarter
+19 061 862 HKD
Last Quarter
–
Current Year
+19 061 862 HKD
Last Year
–
Current Quarter
+19 061 862 HKD
Last Quarter
–
Key Figures 8ZD
1 year
3 years
5 years
10 years
EBITDA
-30 355 964 HKD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-1.03 %
PEG Ratio
–
Return On Equity TTM
-0.74 %
Wall Street Target Price
88.24 HKD
Revenue TTM
497 321 545 HKD
Book Value
3.35 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2509 %
Dividend Yield
–
Gross Profit TTM
22 684 215 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
-3.26 %
Dividend Analytics 8ZD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 8ZD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 8ZD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.754
Price Sales TTM
5.4193
Enterprise Value EBITDA
4.4691
Price Book MRQ
1.154
Financials 8ZD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 8ZD
For 52 weeks
2.05 HKD
4.69 HKD
50 Day MA
3.45 HKD
Shares Short Prior Month
–
200 Day MA
3.07 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart